Pacific Biosciences Of California (PACB) Research & Development (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Research & Development of $19.6 million for Q1 2026, down 32.51% year-over-year from $29.1 million in Q1 2025, and down 14.3% quarter-over-quarter from $22.9 million in Q4 2025.
Pacific Biosciences Of California (PACB) Research & Development (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Research & Development history runs 17 years deep, the most recent figure standing at $19.6 million for Q1 2026.
- In Q1 2026, Research & Development fell 32.51% year-over-year to $19.6 million; the TTM figure through Mar 2026 stood at $87.9 million (down 27.1% YoY), while the FY2025 annual figure was $97.3 million, down 27.88% from the prior year.
- Research & Development for Q1 2026 stood at $19.6 million, down from $22.9 million in the prior quarter.
- The five-year high for Research & Development was $52.9 million in Q1 2022, with the low at $19.6 million in Q1 2026.
- The 5-year median for Research & Development is $42.6 million (2022), against an average of $37.2 million.
- The sharpest annual moves came in 2022 and 2024: Research & Development soared 157.63% in 2022, then slumped 46.3% in 2024.
- Pacific Biosciences Of California's Research & Development stood at $42.6 million in 2022, then increased by 4.51% to $44.5 million in 2023, then tumbled by 38.34% to $27.5 million in 2024, then fell by 16.7% to $22.9 million in 2025, then fell by 14.3% to $19.6 million in 2026.
- Business Quant data shows PACB's Research & Development at $19.6 million in Q1 2026, $22.9 million in Q4 2025, and $22.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 23.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.02 Mn |
| Mar 31, 2026 | 19.61 Mn |
| Dec 31, 2025 | 22.88 Mn |
| Sep 30, 2025 | 22.85 Mn |
| Jun 30, 2025 | 22.53 Mn |
| Mar 31, 2025 | 29.05 Mn |
| Dec 31, 2024 | 27.47 Mn |
| Sep 30, 2024 | 25.52 Mn |
| Jun 30, 2024 | 38.49 Mn |
| Mar 31, 2024 | 43.46 Mn |
| Dec 31, 2023 | 44.54 Mn |
| Sep 30, 2023 | 47.51 Mn |
| Jun 30, 2023 | 46.17 Mn |
| Mar 31, 2023 | 48.94 Mn |
| Dec 31, 2022 | 42.62 Mn |
| Sep 30, 2022 | 47.09 Mn |
| Jun 30, 2022 | 50.35 Mn |
| Mar 31, 2022 | 52.94 Mn |
| Dec 31, 2021 | 42.58 Mn |
| Jun 30, 2021 | 22.27 Mn |